Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.39) per share. This is a 21.88 percent decrease over losses of $(0.32) per share from the same period last year.
Related Posts
BEST Brings ChatGPT In Qianyi ERP Software For Multi-Language Product Titles For Cross-border Sellers
BEST Inc. (NYSE: BEST) integrated the natural language processing tool ChatGPT into its
Stocks To Watch As The World Turns To The 2023 UN Climate Change Conference COP28
New agreements are expected to be set in order to avoid a climate catastrophe within this century.
MindMed Publishes Report By Leading FDA Experts Validating MindMed’s MM-120 Drug Development Strategy
Independent Third-Party Firm, Led by Former Senior FDA Officials, Calls Phase 2b Trial "Well-designed" and "Essential"
Report Further Demonstrates that FCM's Proposal to Skip Phase 2 for MM-120